Valor Management LLC

Institutional investor · Portfolio as of Q3 2023

Q3 2023 Summary

Opened 2 positions, exited 3. Portfolio: $372M across 4 positions.

Top Holdings4 positions

Checking export access…
Activity:
HRMY

Harmony Biosciences Holdings, Inc.

11.2M$367.6M98.9%$42.64-23.15%
8 qtrssince 2021-Q4
Unchanged
0
SONDQ
SONDQDelisted

SONDER HOLDINGS INC

476,321$3.9M1.1%$8.210.00%
1 qtr
New
64
GETR
GETRDelisted

GETAROUND INC

31,689$11,0590.0%——
4 qtrssince 2022-Q4
Unchanged
0
RBTC
RBTCDelisted

RUBICON TECHNOLOGIES INC

4,066$8,4570.0%$2.08-11.06%
1 qtr
New
26
$371.5M
AUM
4
Positions
Q3 2023
Filing
HI rating · 1.5/5
Quarterly 13F Value Change
Reported 13F value ($M)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2022-Q2$566,724,000-13.547074195%
2022-Q3$520,522,000-8.15246927958%
2022-Q4$633,961,02621.7933201671%
2023-Q1$379,726,310-40.102578167%
2023-Q2$401,639,3005.77073261002%
2023-Q3$371,545,052-7.49285440942%
Activity profile
$ moved · Q3'23
New36%Increased0%Decreased0%Exited64%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.5 quarters
<1Q50%1-4Q25%1-2Y25%2Y+0%

Valor Management LLC manages $371.5M across 4 positions as of Q3 2023. Top holdings: HRMY (98.9%), SONDQ (1.1%), GETR (0.0%). Fund DNA: Concentrated Value. HoldingsIntel Score: 1.5/5.0.

Top holdings by portfolio weight

Total AUM$372M
HRMY98.94%
SONDQ1.05%
GETR0.00%
RBTC0.00%
RUBICON TECH0.00%
BRDSQ0.00%
SONDQ0.00%

Portfolio allocation by GICS sector

Sectors4
Healthcare98.94%
Consumer Cyclical1.05%
Technology0.00%
Unknown0.00%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Healthcare
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(1.5 / 5.0)
Holdings P&L18
Conviction71
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Top Losers

Checking access…

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Photo credits

Photo:“Warren Buffett at the 2015 SelectUSA Investment Summit”by USA International Trade Administration, cropped,public domainvia Wikimedia Commons

Photo:Leopold Aschenbrenner

Photo:“Cathie Wood ARK Invest Photo”by Caroline Wood, cropped,CC BY-SA 4.0via Wikimedia Commons

Photo:“Valeant Pharmaceuticals' Business Model (headshot)”by Senate Democrats, cropped,CC BY 2.0via Wikimedia Commons

Photo:Harlem Children's Zone

Photo:Mohnish Pabrai

Photo:“Peter Thiel on March 5 2026”by Kantei (The Prime Minister Office of Japan), cropped,CC BY 4.0via Wikimedia Commons

Photo:Charlotte FC

Photo:Ray Dalio

Photo:Himalaya Capital

Photo:Jonathan Kozowyk, Robin Hood

Photo:“Brad Gerstner at the White House 2025 (54581192563)”by The White House, cropped,public domainvia Wikimedia Commons

Photo:SuperReturn North America

Photo:Liz Linder, Harvard Kennedy School

Photo:Oaktree Capital Management

Photo:The Everglades Foundation

Photo:George Soros

Photo:Benjamin Meaker, Point72

Photo:Fundsmith

Photo:“Kenneth C. Griffin photo”by Paul Elledge, cropped,CC BY-SA 4.0via Wikimedia Commons

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used